Embrex sales and marketing update

EMBX's net loss increased to $2 million (41 cents per share) on revenues of $523,465 in the third quarter ended Sept. 30, up from a loss of $1.4 million (34 cents) on revenues of $160,885 in the quarter last year. More than 80 percent of revenues were from product sales and from fees related to the Inovoject egg injection system. ...